glp-1 agonists alternatives to ozempic 10 for 2026 GLP-1 Alternatives to Ozempic: Medical

Compare Mounjaro vs Ozempic to understand their differences, benefits, and effectiveness in medical weight management.

Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist

Results show broad benefits with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions

Diabetic patients prescribed tirzepatide, semaglutide, dulaglutide, and exenatide are less likely to be diagnosed with depression after starting the medication compared to those not on a glucagon-like peptide-1 receptor agonist (GLP-1) medication.

A large global retrospective cohort study (n=331,863 matched patients

Does GLP-1 help with depression